Caldwell Sutter Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Caldwell Sutter Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.8K	Hold	100	–	–	0.01%	560
2026 Q1	$12.8K	Hold	100	–	–	0.01%	532
2025 Q4	$12.2K	Hold	100	–	–	0.01%	526
2025 Q3	$10K	Hold	100	–	–	﹤0.01%	549
2025 Q2	$8.29K	Buy	100 +27	+37%	+$2.15K	﹤0.01%	560
2025 Q1	$5.92K	Buy	73 +20	+38%	+$1.79K	﹤0.01%	605
2024 Q4	$4.77K	Hold	53	–	–	﹤0.01%	639
2024 Q3	$5.24K	Hold	53	–	–	﹤0.01%	633
2024 Q2	$4.91K	Hold	53	–	–	﹤0.01%	635
2024 Q1	$5.03K	Hold	53	–	–	﹤0.01%	633
2023 Q4	$4.73K	Hold	53	–	–	﹤0.01%	637
2023 Q3	$3.87K	Hold	53	–	–	﹤0.01%	640
2023 Q2	$4.41K	Buy	+53	New	+$4.43K	﹤0.01%	627

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Caldwell Sutter Capital's XBI Position: Q2 2026 in Review

Caldwell Sutter Capital held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 100 shares worth $15.8K. The position accounts for 0.01% of the portfolio, ranked #560.

Caldwell Sutter Capital first reported a position in XBI in Q2 2023 and has held it in 13 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Caldwell Sutter Capital held 100 shares of State Street SPDR S&P Biotech ETF worth $15.8K as of Q2 2026.
Caldwell Sutter Capital left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.01% of Caldwell Sutter Capital's portfolio in Q2 2026, its #560 holding.
Caldwell Sutter Capital first reported a position in State Street SPDR S&P Biotech ETF in Q2 2023 and has held it in 13 quarters since.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Caldwell Sutter Capital's 13F filing for Q2 2026, filed 5 Aug 2026.